PRASHI JAIN to Cell Line, Tumor
This is a "connection" page, showing publications PRASHI JAIN has written about Cell Line, Tumor.
Connection Strength
0.025
-
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocr Relat Cancer. 2021 08 13; 28(10):657-670.
Score: 0.025